Alexion Pharmaceuticals, Inc.
Methods for treating tracheobronchomalacia
Last updated:
Abstract:
The disclosure features methods for treating tracheobronchomalacia (TBM) in a patient having hypophosphatasia (HPP), such as an infant, by administering a soluble alkaline phosphatase (sALP) to the patient.
Status:
Grant
Type:
Utility
Filling date:
18 Aug 2017
Issue date:
14 Sep 2021